PBYI financials
Puma Biotechnology (PBYI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PBYI income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $228.37M | $170.21M | $37.30M | $31.11M | 0.61 |
| 2024 | $230.47M | $166.06M | $30.97M | $30.28M | 0.62 |
| 2023 | $235.64M | $172.96M | $32.64M | $21.59M | 0.45 |
| 2022 | $228.03M | $172.94M | $23.72M | $2.00K | 0.02 |
| 2021 | $253.16M | $189.45M | $1.29M | -$29.13M | -0.72 |
| 2020 | $225.11M | $185.74M | -$30.40M | -$59.99M | -1.52 |
- PBYI revenue was $228.37M in fiscal 2025, net income $31.11M.
Updated 2026-11-07 11:50 UTC